Acotec Scientific Holdings Limited

Research Acotec Scientific Holdings Limited (6669.HK) on Bullrun: market cap HKD 1.82B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 1.82B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 644.63MCNY 119.18MCNY 69.12M73.9%0.39CNY 399.82MCNY 244.39MCNY 1.48B
FY2024CNY 533.99MCNY 52.28MCNY 5.31M75.4%0.17CNY 751.39MCNY 202.92MCNY 1.35B
FY2023CNY 473.85MCNY 14.49M-CNY 92.54M79.6%0.05CNY 637.63MCNY 234.00MCNY 1.30B
FY2022CNY 395.55MCNY 70.14M-CNY 115.45M85.0%0.23CNY 986.46MCNY 47.78MCNY 1.28B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 1.82Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About Acotec Scientific Holdings Limited

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with a vascular interventional approach;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Acotec Scientific Holdings Limited's market cap?

Acotec Scientific Holdings Limited's market capitalization is HKD 1.82B.

What does Acotec Scientific Holdings Limited do?

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally.